SARS and Common Viral Infections

SARS and Common Viral Infections

Janice K. Louie, Jill K. Hacker, Jennifer Mark, Shilpa S. Gavali, Shigeo Yagi, Alex Espinosa, David P. Schnurr, Cynthia K. Cossen, Erin R. Isaacson, Carol A. Glaser, Marc Fischer, Arthur L Reingold, Duc J. Vugia

In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspect SARS and 9 (47%) of 19 patients with probable SARS.

2004

severe acute respiratory syndrome, SARS, Polymerase Chain Reaction, molecular testing, United States

DOI: 10.3201/eid1006.030863

Emerging Infectious Diseases

Centers for Disease Control and Prevention

Infectious and parasitic diseases, Medicine

EN